Microarray patch (MAP) technologies can address the need for improved presentations of vaccines and pharmaceuticals. The PATH Center of Excellence for MAP Technology is working to advance MAP development for high priority needs in low- and middle-income countries (LMICs). A key element of this work is evaluating global health use cases and understanding potential usability, acceptability, and programmatic fit of MAPs for specific applications and use cases.

This report provides a summary of the user and program needs activities for a rabies vaccine MAP and includes feedback from both in-country stakeholders in India and global stakeholders along with recommendations for minimal and optimal product requirements.